Table 1.
Demographic, disease, motor, and cognitive characteristics
| Control (N = 13) | PDFOG− (N = 13) | PDFOG+ (N = 13) | p Value | |
|---|---|---|---|---|
| Gender, M/F | 8/5 | 9/4 | 8/5 | |
| Age, years | 69 (2.3) | 65.2 (2.4) | 69.5 (2.6) | >0.05a |
| Disease Duration, years | - | 4.8 (1.0) | 7.5 (1.0) | 0.06b |
| LED, mg/day | - | 682.7 (99.1) | 1158.8 (134.4) | 0.01b |
| Cognition Characteristics | ||||
| MOCA (0–30) | 26.6 (0.53) | 24.8 (0.8) | 21.8 (1.2) | <0.01a |
| Motor Characteristics | ||||
| UPDRS III (0–56) | - | 10.5 (1.7) | 19.2 (1.3) | <0.01b |
| H & Y stage, on (1–5) | - | 1.6 (0.2) | 2.4 (0.3) | 0.03b |
| Freezing of Gait (FOG) | ||||
| FOG questionnaire (0–24) | - | 3.7 (0.9) | 14.8 (0.8) | <0.01b |
Values were expressed as mean (standard error of mean).
One-way ANOVA was applied when three groups were compared followed by
a
two-sample t test to compare between PDFOG+ vs. control subjects.
b
Two-sample t test was used for comparison between PDFOG− vs PDFOG.
Abbreviations: Male, M; Female, F; Montreal Cognitive Assessment, MOCA; motor Unified Parkinson’s Disease Rating Scale, UPDRS III; Hoehn & Yahr scale, H & Y.